AAAAAA
Results: 1-25/64
Authors:
Fulda, S
Meyer, E
Friesen, C
Susin, SA
Kroemer, G
Debatin, KM
Citation: S. Fulda et al., Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis, ONCOGENE, 20(9), 2001, pp. 1063-1075
Authors:
Fulda, S
Kufer, MU
Meyer, E
van Valen, F
Dockhorn-Dworniczak, B
Debatin, KM
Citation: S. Fulda et al., Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer, ONCOGENE, 20(41), 2001, pp. 5865-5877
Authors:
Beltinger, C
Uckert, W
Debatin, KM
Citation: C. Beltinger et al., Suicide gene therapy for pediatric tumors, J MOL MED-J, 78(11), 2001, pp. 598-612
Authors:
Debatin, KM
Citation: Km. Debatin, Cell death in T- and B-cell development, ANN HEMATOL, 80, 2001, pp. B29-B31
Authors:
Goldbeck, L
Braun, J
Storck, M
Tonnessen, D
Weyhreter, H
Debatin, KM
Citation: L. Goldbeck et al., Adaptation of parents to the diagnosis of a chronic disease in their child, PSY PSY MED, 51(2), 2001, pp. 62-67
Authors:
Lindner, W
Behnisch, W
Kunz, U
Debatin, KM
Pohlandt, F
Citation: W. Lindner et al., Congenital neuroblastoma mimicking early onset sepsis, EUR J PED, 160(7), 2001, pp. 436-438
Authors:
Wabitsch, M
Brenner, RE
Melzner, I
Braun, M
Moller, P
Heinze, E
Debatin, KM
Hauner, H
Citation: M. Wabitsch et al., Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation, INT J OBES, 25(1), 2001, pp. 8-15
Authors:
Scheuerpflug, CG
Lichter, P
Debatin, KM
Mincheva, A
Citation: Cg. Scheuerpflug et al., Assignment of TRADD to human chromosome band 16q22 by in situ hybridization, CYTOG C GEN, 92(3-4), 2001, pp. 347-348
Authors:
Ege, M
Manfras, BJ
Barbi, G
Schulz, AS
Sigl-Kraetzig, M
Debatin, KM
Friedrich, W
Mueller, SM
Citation: M. Ege et al., Eradication of a dysfunctional HLA-haploidentical T cell system by a second HLA-identical BMT, BONE MAR TR, 28(10), 2001, pp. 993-995
Authors:
Classen, CF
Schulz, AS
Sigl-Kraetzig, M
Hoffmann, GF
Simmonds, HA
Fairbanks, L
Debatin, KM
Friedrich, W
Citation: Cf. Classen et al., Successful HLA-identical bone marrow transplantation in a patient with PNPdeficiency using busulfan and fludarabine for conditioning, BONE MAR TR, 28(1), 2001, pp. 93-96
Authors:
Wang, Y
Hofmann, TG
Runkel, L
Haaf, T
Schaller, H
Debatin, KM
Hug, H
Citation: Y. Wang et al., Isolation and characterization of cDNAs for the protein kinase HIPK2, BBA-GENE ST, 1518(1-2), 2001, pp. 168-172
Authors:
Bohler, T
Wintergerst, U
Linde, R
Belohradsky, BH
Debatin, KM
Citation: T. Bohler et al., CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with diseaseprogression in HIV-infected children and adolescents: Effect of highly active antiretroviral therapy (HAART), PEDIAT RES, 49(1), 2001, pp. 101-110
Authors:
Beltinger, C
Debatin, KM
Citation: C. Beltinger et Km. Debatin, Murine models for experimental therapy of pediatric solid tumors with poorprognosis, INT J CANC, 92(3), 2001, pp. 313-318
Authors:
Jeremias, I
Reinhardt, D
Debatin, KM
Citation: I. Jeremias et al., Dysregulation of apoptosis as the basis of disease, HNO, 49(8), 2001, pp. 673-683
Authors:
Classen, CF
Schulz, AS
Debatin, KM
Friedrich, W
Citation: Cf. Classen et al., Severe persistent neuropsychiatric toxicity after a human leucocyte antigennon-identical peripheral blood stem cell transplantation (total body irradiation, etoposide, thiotepa) and interleukin 2-based experimental therapy for poor prognosis relapse acute lymphoblastic leukaemia, BR J HAEM, 114(2), 2001, pp. 487-489
Authors:
Herr, I
Debatin, KM
Citation: I. Herr et Km. Debatin, Cellular stress response and apoptosis in cancer therapy, BLOOD, 98(9), 2001, pp. 2603-2614
Authors:
Stahnke, K
Fulda, S
Friesen, C
Strauss, G
Debatin, KM
Citation: K. Stahnke et al., Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy, BLOOD, 98(10), 2001, pp. 3066-3073
Authors:
Bohler, T
Debatin, KM
Wintergerst, U
Citation: T. Bohler et al., T-cell apoptosis in HIV-1-infected individuals receiving highly active antiretroviral therapy, BLOOD, 97(6), 2001, pp. 1898-1900
Authors:
Herr, I
Posovsky, C
Bohler, T
Debatin, KM
Citation: I. Herr et al., mAb 33 from Transduction Laboratories specifically binds to human CD95-L, CELL DEAT D, 7(1), 2000, pp. 129-130
Authors:
Herr, I
Posovszky, C
Di Marzio, L
Cifone, MG
Boehler, T
Debatin, KM
Citation: I. Herr et al., Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha, ONCOGENE, 19(37), 2000, pp. 4255-4262
Authors:
Herr, I
Krilleke, D
Debatin, KM
Citation: I. Herr et al., A sensitive, non-radioactive and fast method for detection of JNK/SAPK activity in leukemic T cells, LEUKEMIA, 14(10), 2000, pp. 1859-1860
Authors:
Fellenberg, J
Mau, H
Nedel, S
Ewerbeck, V
Debatin, KM
Citation: J. Fellenberg et al., Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction, J ORTHOP R, 18(1), 2000, pp. 10-17
Authors:
Debatin, KM
Citation: Km. Debatin, Activation of apoptosis pathways by anticancer treatment, TOX LETT, 112, 2000, pp. 41-48
Authors:
Kolbus, A
Herr, I
Schreiber, M
Debatin, KM
Wagner, EF
Angel, P
Citation: A. Kolbus et al., c-Jun-dependent CD95-L expression is a rate-limiting step in the inductionof apoptosis by alkylating agents, MOL CELL B, 20(2), 2000, pp. 575-582
Authors:
Fulda, S
Lutz, W
Schwab, M
Debatin, KM
Citation: S. Fulda et al., MycN sensitizes neuroblastoma cells for drug-triggered apoptosis, MED PED ONC, 35(6), 2000, pp. 582-584